Related Experiment Video
Updated: Apr 19, 2026

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
Published on: February 22, 2022
Murine cardiac growth, TRPC channels, and cGMP kinase I
Katrin Domes1, Enrico Patrucco1, Florian Loga1
1FOR923, Institut für Pharmakologie und Toxikologie, Technische Universität München, Biedersteiner Str. 29, 80802, Munich, Germany.
Abstract:
Signaling via cGMP-dependent protein kinase I (cGKI) and canonical transient receptor potential (TRPC) channels appears to be involved in the regulation of cardiac hypertrophy. Recent evidence suggests that TRPC channels are targets for cGKI, and phosphorylation of these channels may mediate the antihypertrophic effects of cGMP signaling. We tested this concept by investigating the role of cGMP/cGKI signaling on angiotensin II (A II)-induced cardiac hypertrophy using a control group (Ctr), trpc6(-/-), trpc3(-/-), trpc3(-/-)/6(-/-), βRM mice, and trpc3(-/-)/6(-/-) × βRM mice. βRM mice express cGKIβ only in the smooth muscle on a cGKI(-/-) background. The control group was composed of littermate mice that contained at least one wild type gene of the respective genotype. A II was infused by minipumps (7 days; 2 mg/kg/day) in Ctr, trpc6(-/-), trpc3(-/-), trpc3(-/-)/6(-/-), βRM, and trpc3(-/-)/6(-/-) × βRM mice. Hypertrophy was assessed by measuring heart weight per tibia length (HW/TL) and fibrosis by staining of heart slices. A II-induced increase in HW/TL and fibrosis was absent in trpc3 (-/-) mice, whereas an increase in HW/TL and fibrosis was evident in Ctr and trpc6(-/-), minimal or absent in trpc3(-/-), moderate in βRM, and dramatic in trpc3(-/-)/6(-/-) βRM mice. These results suggest that TRPC3 may be necessary for A II-induced cardiac hypertrophy. On the other hand, hypertrophy and fibrosis were massively increased in βRM mice on a TRPC3/6 × cGKI(-/-)KO background, indicating an "additive" coupling between both signaling pathways.
Insights
Transient Receptor Potential Canonical 3 (TRPC3) channels are essential for angiotensin II-induced cardiac hypertrophy. Disrupting TRPC3 prevents hypertrophy, while combined TRPC3/6 and cGMP-dependent protein kinase I (cGKI) disruption exacerbates it.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Ion Channel Physiology
Background:
- Cardiac hypertrophy is regulated by cGMP-dependent protein kinase I (cGKI) and canonical transient receptor potential (TRPC) channels.
- TRPC channels are potential targets of cGKI, with phosphorylation mediating cGMP's antihypertrophic effects.
Purpose of the Study:
- To investigate the role of cGMP/cGKI signaling in angiotensin II (A II)-induced cardiac hypertrophy.
- To determine if TRPC3 and TRPC6 channels mediate the effects of cGMP signaling on cardiac hypertrophy.
Main Methods:
- Utilized various genetically modified mouse models: wild-type controls, trpc6(-/-), trpc3(-/-), trpc3(-/-)/6(-/-), $\beta$RM mice (smooth muscle-specific cGKI$\\beta$ expression), and trpc3(-/-)/6(-/-) x $\beta$RM mice.
- Administered angiotensin II (A II) via minipumps for 7 days.
- Assessed cardiac hypertrophy by heart weight to tibia length ratio (HW/TL) and cardiac fibrosis via heart slice staining.
Main Results:
- A II-induced cardiac hypertrophy and fibrosis were absent in trpc3(-/-) mice.
- Significant increases in HW/TL and fibrosis were observed in control and trpc6(-/-) mice.
- Hypertrophy was minimal in trpc3(-/-) mice, moderate in $\beta$RM mice, and dramatically increased in trpc3(-/-)/6(-/-) x $\beta$RM mice.
- An additive interaction between TRPC3/6 and cGKI pathways was indicated by massive hypertrophy in double knockout mice.
Conclusions:
- TRPC3 channels are necessary for angiotensin II-induced cardiac hypertrophy.
- The interplay between TRPC channels and cGKI signaling is crucial in regulating cardiac hypertrophy, with TRPC3 playing a key role.
More Related Videos
Related Concept Videos
G-Protein Gated Ion Channels
Sensory...
Activation and Inactivation of G Proteins
GPCRs Regulate Adenylyl Cylase Activity
IP3/DAG Signaling Pathway
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

